BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 635505)

  • 1. [Certain and disputed indications of immunosuppressive therapy in kidney diseases].
    Hodler J; Wegmüller E; Frey B; Grüninger U
    Schweiz Med Wochenschr; 1978 Mar; 108(12):444-52. PubMed ID: 635505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy of primary glomerulonephritis].
    Ritz E; Mickisch O
    Internist (Berl); 1989 Mar; 30(3):180-95. PubMed ID: 2654060
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma exchange in nephrological diseases.
    Mason PD; Pusey CD
    Curr Stud Hematol Blood Transfus; 1990; (57):152-66. PubMed ID: 2148716
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of glomerulonephritis (author's transl)].
    Thiel G
    Ther Umsch; 1982 May; 39(5):341-50. PubMed ID: 7101214
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dietetics in renal pathology].
    Prost MO
    Z Krankenpfl; 1973 Mar; 66(3):104-9. PubMed ID: 4487447
    [No Abstract]   [Full Text] [Related]  

  • 8. [Conservative long-term therapy of chronic kidney diseases].
    Mampel E; Ahrens I; Koall W
    Z Gesamte Inn Med; 1973 Mar; 28(6):Suppl:93-5. PubMed ID: 4196734
    [No Abstract]   [Full Text] [Related]  

  • 9. [Supply and restriction of protein in kidney diseases].
    Gerhardt W
    Landarzt; 1967 Aug; 43(22):1075-7. PubMed ID: 5587429
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of mycophenolic acid in non-transplant renal diseases.
    Stassen PM; Kallenberg CG; Stegeman CA
    Nephrol Dial Transplant; 2007 Apr; 22(4):1013-9. PubMed ID: 17307748
    [No Abstract]   [Full Text] [Related]  

  • 11. What is new in therapy of glomerulonephritis in 2003/2004.
    Hruby Z
    Rocz Akad Med Bialymst; 2004; 49():166-9. PubMed ID: 15631335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological diagnosis of kidney diseases and its importance in the immunodepressant therapy].
    Arutiunian SK; Tumanian AM; Barsegian BA; Arutiunian VM; Grigorian GS
    Zh Eksp Klin Med; 1974; 14(4):78-84. PubMed ID: 4425184
    [No Abstract]   [Full Text] [Related]  

  • 13. [The immunosuppressive therapy of chronic (Bright's) nephritis].
    Krasnova TN; Shilov EM
    Ter Arkh; 1993; 65(6):88-93. PubMed ID: 8378860
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of primary chronic glomerulonephritis].
    Risler T; Braun N; Erley CM
    Ther Umsch; 1994 Dec; 51(12):807-12. PubMed ID: 7784993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in nephrology, renal dialysis and transplantation.
    Eales L
    S Afr Med J; 1970 Jun; 44(26):747-52. PubMed ID: 4914759
    [No Abstract]   [Full Text] [Related]  

  • 16. Resolved: in minimizing kidney transplant immunosuppression, steroids should go before calcineurin inhibitors: con.
    Pavlakis M
    J Am Soc Nephrol; 2007 Dec; 18(12):3028-30. PubMed ID: 18046783
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of chronic glomerulonephritis and pyelonephritis].
    Ar'eva EM; Iaroshevskiĭ AIa
    Voen Med Zh; 1971 Mar; 3():46-52. PubMed ID: 5125138
    [No Abstract]   [Full Text] [Related]  

  • 18. Resolved: in minimizing kidney transplant immunosuppression, steroids should go before calcineurin inhibitors: pro.
    Matas AJ
    J Am Soc Nephrol; 2007 Dec; 18(12):3026-8. PubMed ID: 18003783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional consideration of kidney diseases as the basis for therapy].
    Wollheim E
    Med Welt; 1970 May; 20():913-20. PubMed ID: 5510795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.